Skip to content
★ Sign in to follow
MD

Martin Diggle

Proteome Sciences PLC
Total declarations
8
Company
1
▲ Purchases (8 ops.)
€153k
▼ Sales (0 ops.)
—

Latest filing published 07 Jul 2020 for Proteome Sciences Plc, €4,326.

Filing timeline

BuySale
Martin Diggle

Insider track record

Disclosed buys
8
Disclosed sells
0
Signal history

Closed purchases

Market purchases
8

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Martin Diggle: trading record in brief

Martin Diggle appears in our data through filings on Proteome Sciences PLC shares, published by RNS (LSE). The record holds 8 filings, for trades running from 12 November 2018 to 3 July 2020.

Purchases make up the whole of the open-market record (8 purchases, €153k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2020: 3 purchases and no sales on the market.

A typical purchase (the median) is worth €19k. The 3 purchases reviewed show no overlap with other insiders buying the same stock within a month.

The record was last updated on 7 July 2020 with an open-market purchase (€4,326) in Proteome Sciences PLC. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for notifying a trade is three business days (UK MAR). Source: insider filings from RNS (LSE). Past trades are no guide to future returns.

Companies and markets linked to Martin Diggle

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total
  • ▲
    Non-Executive DirectorExecutivesProteome Sciences PLC
    3,900 GBP11FCA-NSM
    99,999 shares@ £0.03938.5% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:3649245
    Canonical exit: 1 Oct 2020 (T+90)
  • ▲
    Non-Executive DirectorExecutivesProteome Sciences PLC
    6,240 GBP13FCA-NSM
    160,000 shares@ £0.03961.5% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:3645372
    Canonical exit: 29 Sept 2020 (T+90)
  • ▲
    Non-Executive DirectorExecutivesProteome Sciences PLC
    7,693 GBP11FCA-NSM
    256,424 shares@ £0.0344.5% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:LSE20200303070009_3512956_20200331164955746_2001
    Canonical exit: 28 May 2020 (T+90)
  • ▲
    Non-Executive DirectorExecutivesProteome Sciences PLC
    31,600 GBP0FCA-NSM
    1,000,000 shares@ £0.0316London Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:LSE20181126163814_13880782_20200330111438044_5885
    Canonical exit: 21 Feb 2019 (T+90)
  • ▲
    Non-Executive DirectorExecutivesProteome Sciences PLC
    16,200 GBP0FCA-NSM
    500,000 shares@ £0.0324London Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:LSE20181123132617_13878856_20200330111438120_7497
    Canonical exit: 20 Feb 2019 (T+90)
  • ▲
    Non-Executive DirectorExecutivesProteome Sciences PLC
    17,100 GBP0FCA-NSM
    500,000 shares@ £0.0342London Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:LSE20181121094134_13875381_20200330111438257_10340
    Canonical exit: 17 Feb 2019 (T+90)
  • ▲
    Non-Executive DirectorExecutivesProteome Sciences PLC
    17,100 GBP0FCA-NSM
    500,000 shares@ £0.0342London Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:LSE20181116143517_13870557_20200330111438444_14310
    Canonical exit: 14 Feb 2019 (T+90)
  • ▲
    Non-Executive DirectorExecutivesProteome Sciences PLC
    35,000 GBP0FCA-NSM
    1,000,000 shares@ £0.035London Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:LSE20181114121028_13866944_20200330111438581_17202
    Canonical exit: 10 Feb 2019 (T+90)

8 of 8 declarations